PROM1 and brain cancer: The work of Bao et al. [29], conducted in animal models using primary human gliomas, showed that CD133 (Prominin-1), a marker for both neural stem cells and brain cancer stem cells, was not only enriched after irradiation but also capable of initiating xenografts from as few as 500 cells.